Product Code: SR112023A5665
Market Overview:
The global syringes market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
Syringes are medical devices used by healthcare professionals to withdraw fluid from the body or inject medication through intravenous (IV) or intramuscular ways into the bloodstream. They assist in managing the medical conditions of people, including psoriasis, allergies, arthritis, cancer, diabetes, hepatitis, infertility, migraines, multiple sclerosis, osteoporosis, blood clotting disorders, and human immunodeficiency virus (HIV). Several manufacturers are currently adopting advanced manufacturing processes and quality assurance procedures to produce syringes that provide research and development (R&D) personnel with superior accuracy and precision during auto sampling.
Syringes Market Trends:
Governments of numerous countries are encouraging the fast and safe vaccination of people to reduce their probability of contracting coronavirus disease (COVID-19). This represents one of the key factors driving the need for effective syringes to meet vaccination targets. Apart from this, the growing prevalence of chronic diseases and the increasing healthcare-associated infection (HAI) cases are catalyzing the adoption of disposable syringes that are cost-effective, ready to use, and made of plastic. In addition to this, a significant rise in the percentage of people who are undergoing surgical interventions is augmenting the demand for single-use syringes for delivering anesthetics. Besides this, various initiatives, such as installing sharp containers in public places, undertaken by health agencies to address the increasing number of used syringes and promote safe injection practices are impelling the growth of the market. Furthermore, as farm animals are commonly exposed to diseases that can spread to humans, the increasing consumption of animal-derived products and the rising concerns about food safety are escalating the demand for combined vaccines and syringes. This can also be attributed to the growing adoption of companion animals and the emerging pet ownership and humanization trends.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global syringes market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, material, usage, distribution channel and end user.
Breakup by Product:
General Syringes
Specialized Syringes
Insulin Syringes
Tuberculin Syringes
Allergy Syringes
Others
Breakup by Material:
Glass Syringes
Polymer Syringes
Breakup by Usage:
Disposable Syringes
Conventional Syringes
Safety Syringes
Prefilled Syringes
Reusable Syringes
Breakup by Distribution Channel:
Offline
Online
Breakup by End User:
Hospitals and Clinics
Diagnostic Centers
Speciality Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation and Thomas Scientific LLC.
Key Questions Answered in This Report
- 1. What was the size of the global syringes market in 2022?
- 2. What is the expected growth rate of the global syringes market during 2023-2028?
- 3. What are the key factors driving the global syringes market?
- 4. What has been the impact of COVID-19 on the global syringes market?
- 5. What is the breakup of the global syringes market based on the product?
- 6. What is the breakup of the global syringes market based on the material?
- 7. What is the breakup of the global syringes market based on usage?
- 8. What are the key regions in the global syringes market?
- 9. Who are the key players/companies in the global syringes market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Syringes Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 General Syringes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Specialized Syringes
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Insulin Syringes
- 6.2.2.2 Tuberculin Syringes
- 6.2.2.3 Allergy Syringes
- 6.2.3 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Material
- 7.1 Glass Syringes
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Polymer Syringes
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Usage
- 8.1 Disposable Syringes
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Conventional Syringes
- 8.1.2.2 Safety Syringes
- 8.1.2.3 Prefilled Syringes
- 8.1.3 Market Forecast
- 8.2 Reusable Syringes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Offline
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Online
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by End User
- 10.1 Hospitals and Clinics
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Diagnostic Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Speciality Centers
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 B. Braun Melsungen AG
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 SWOT Analysis
- 16.3.2 Baxter International Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Becton Dickinson and Company
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Cardinal Health Inc.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Gerresheimer AG
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.6 Hindustan Syringes & Medical Devices Ltd.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 Nipro Corporation
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Pfizer Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Retractable Technologies Inc.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Schott AG
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 SWOT Analysis
- 16.3.11 Smiths Group plc
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.12 Terumo Corporation
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.13 Thomas Scientific LLC
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio